<VariationArchive VariationID="136176" VariationName="NM_001365088.1(SLC12A6):c.2032dup (p.Tyr678fs)" VariationType="Duplication" Accession="VCV000136176" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-01-26" DateCreated="2013-09-18" MostRecentSubmission="2024-01-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="139888" VariationID="136176">
      <GeneList>
        <Gene Symbol="SLC12A6" FullName="solute carrier family 12 member 6" GeneID="9990" HGNC_ID="HGNC:10914" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q14</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="34229784" stop="34338057" display_start="34229784" display_stop="34338057" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NW_025791798.1" start="3625" stop="76798" display_start="3625" display_stop="76798" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="34522196" stop="34630264" display_start="34522196" display_stop="34630264" Strand="-" />
          </Location>
          <OMIM>604878</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001365088.1(SLC12A6):c.2032dup (p.Tyr678fs)</Name>
      <CanonicalSPDI>NC_000015.10:34243983:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q14</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="34243983" stop="34243984" display_start="34243983" display_stop="34243984" variantLength="1" positionVCF="34243983" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="34536184" stop="34536185" display_start="34536184" display_stop="34536185" variantLength="1" positionVCF="34536184" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <OtherNameList>
        <Name>NP_598408.1:p.Tyr678LeufsTer41</Name>
      </OtherNameList>
      <ProteinChange>Y669fs</ProteinChange>
      <ProteinChange>Y678fs</ProteinChange>
      <ProteinChange>Y627fs</ProteinChange>
      <ProteinChange>Y663fs</ProteinChange>
      <ProteinChange>Y619fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_270" sequenceAccession="LRG_270">
            <Expression>LRG_270:g.99081dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_270t1" sequenceAccession="LRG_270t1">
            <Expression>LRG_270t1:c.1879dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_270p1" sequenceAccession="LRG_270p1" change="p.Tyr627fs">
            <Expression>LRG_270p1:p.Tyr627fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_270t2" sequenceAccession="LRG_270t2">
            <Expression>LRG_270t2:c.2032dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_270p2" sequenceAccession="LRG_270p2" change="p.Tyr678fs">
            <Expression>LRG_270p2:p.Tyr678fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.34243984dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.34243984dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.34536185dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.34536185dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007951.1" sequenceAccession="NG_007951" sequenceVersion="1" change="g.99081dup">
            <Expression>NG_007951.1:g.99081dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042494.2" sequenceAccession="NM_001042494" sequenceVersion="2" change="c.1855dup">
            <Expression>NM_001042494.2:c.1855dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035959.1" sequenceAccession="NP_001035959" sequenceVersion="1" change="p.Tyr619fs">
            <Expression>NP_001035959.1:p.Tyr619fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042495.2" sequenceAccession="NM_001042495" sequenceVersion="2" change="c.1855dup">
            <Expression>NM_001042495.2:c.1855dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035960.1" sequenceAccession="NP_001035960" sequenceVersion="1" change="p.Tyr619fs">
            <Expression>NP_001035960.1:p.Tyr619fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042496.2" sequenceAccession="NM_001042496" sequenceVersion="2" change="c.2005dup">
            <Expression>NM_001042496.2:c.2005dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035961.1" sequenceAccession="NP_001035961" sequenceVersion="1" change="p.Tyr669fs">
            <Expression>NP_001035961.1:p.Tyr669fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042497.2" sequenceAccession="NM_001042497" sequenceVersion="2" change="c.1987dup">
            <Expression>NM_001042497.2:c.1987dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035962.1" sequenceAccession="NP_001035962" sequenceVersion="1" change="p.Tyr663fs">
            <Expression>NP_001035962.1:p.Tyr663fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365088.1" sequenceAccession="NM_001365088" sequenceVersion="1" change="c.2032dup" MANESelect="true">
            <Expression>NM_001365088.1:c.2032dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352017.1" sequenceAccession="NP_001352017" sequenceVersion="1" change="p.Tyr678fs">
            <Expression>NP_001352017.1:p.Tyr678fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005135.2" sequenceAccession="NM_005135" sequenceVersion="2" change="c.1879dup">
            <Expression>NM_005135.2:c.1879dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005126.1" sequenceAccession="NP_005126" sequenceVersion="1" change="p.Tyr627fs">
            <Expression>NP_005126.1:p.Tyr627fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_133647.2" sequenceAccession="NM_133647" sequenceVersion="2" change="c.2032dup">
            <Expression>NM_133647.2:c.2032dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_598408.1" sequenceAccession="NP_598408" sequenceVersion="1" change="p.Tyr678fs">
            <Expression>NP_598408.1:p.Tyr678fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA345671" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604878.0005" DB="OMIM" />
        <XRef Type="rs" ID="515726217" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001365088.1(SLC12A6):c.2032dup (p.Tyr678fs) AND Agenesis of the corpus callosum with peripheral neuropathy" Accession="RCV000123393" Version="5">
        <ClassifiedConditionList TraitSetID="1484">
          <ClassifiedCondition DB="MedGen" ID="C0795950">Agenesis of the corpus callosum with peripheral neuropathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-04-11" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2006-04-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-09-18" MostRecentSubmission="2024-01-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16606917</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301546</ID>
          <ID Source="BookShelf">NBK1372</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1484" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Andermann syndrome</ElementValue>
                <XRef ID="Andermann+Syndrome/429" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charlevoix disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Corpus callosum agenesis neuronopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyneuropathy, sensorimotor, with or without agenesis of the corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with neuronopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with peripheral neuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agenesis of corpus callosum with polyneuropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HMSN/ACC</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Agenesis of the corpus callosum with peripheral neuropathy</ElementValue>
                <XRef ID="MONDO:0000902" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACCPN</ElementValue>
                <XRef Type="MIM" ID="218000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary motor and sensory neuropathy with agenesis of the corpus callosum (HMSN/ACC), a neurodevelopmental and neurodegenerative disorder, is characterized by severe progressive sensorimotor neuropathy with resulting hypotonia, areflexia, and amyotrophy, and by variable degrees of dysgenesis of the corpus callosum. Mild-to-severe intellectual disability and "psychotic episodes" during adolescence are observed. Sensory modalities are moderately to severely affected beginning in infancy. The average age of onset of walking is 3.8 years; the average age of loss of walking is 13.8 years; the average age of death is 33 years.</Attribute>
                <XRef ID="NBK1372" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000264022" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553541" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525862" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552164" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525863" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1537" />
                <XRef ID="1537" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301546</ID>
                <ID Source="BookShelf">NBK1372</ID>
              </Citation>
              <XRef ID="1496" DB="Orphanet" />
              <XRef ID="C0795950" DB="MedGen" />
              <XRef ID="MONDO:0000902" DB="MONDO" />
              <XRef Type="MIM" ID="218000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="288258" SubmissionDate="2014-06-13" DateLastUpdated="2022-10-01" DateCreated="2014-06-23">
        <ClinVarSubmissionID localKey="NM_133647.1:c.2032dup|OMIM:218000" />
        <ClinVarAccession Accession="SCV000166719" DateUpdated="2022-10-01" DateCreated="2014-06-23" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1372</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>German</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NP_598408.1:p.Tyr678LeufsTer41</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_133647.1:c.2032dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0795950" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>epb42-spherocytosis_4-24-2014</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="25836" SubmissionDate="2013-09-16" DateLastUpdated="2024-01-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604878.0005_AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY" title="SLC12A6, 1-BP INS, 2031T_AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY" />
        <ClinVarAccession Accession="SCV000025836" DateUpdated="2024-01-26" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-04-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3.5-year-old German girl with agenesis of the corpus callosum with peripheral neuropathy (ACCPN; 218000), Uyanik et al. (2006) identified compound heterozygosity for 2 mutations in the SLC12A6 gene: a 1-bp insertion (c.2031insT) and an 8-bp deletion (604878.0006). Both mutations were predicted to result in a frameshift and premature termination of the protein. Each unaffected parent was heterozygous for 1 of the mutations.</Attribute>
              <Citation>
                <ID Source="PubMed">16606917</ID>
              </Citation>
              <XRef DB="OMIM" ID="218000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC12A6" />
          </GeneList>
          <Name>SLC12A6, 1-BP INS, 2031T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 2031T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604878.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="25836" TraitType="Disease" MappingType="Name" MappingValue="AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY" MappingRef="Preferred">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="288258" TraitType="Disease" MappingType="XRef" MappingValue="C0795950" MappingRef="MedGen">
        <MedGen CUI="C0795950" Name="Agenesis of the corpus callosum with peripheral neuropathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

